On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

FXN

frataxin

The FXN gene provides instructions for producing the frataxin protein, which is primarily located in the mitochondria and plays a role in iron-sulphur cluster assembly. The FXN gene encodes the frataxin protein, crucial for normal mitochondrial function and energy production within cells.

Chromosome 9q21.11 Various HGNC:3951 Tier C
FXN 9q21.11 p arm q arm 9

FXN is located on the long (q) arm of chromosome 9, at band 9q21.11. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 9 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The FXN gene is responsible for synthesising the frataxin protein, which is found in various tissues throughout the body, including the heart, spinal cord, liver, pancreas, and skeletal muscles. The protein is predominantly located within the mitochondria, the cell's powerhouses, where it participates in fundamental metabolic processes.

Disruptions to the FXN gene's normal function, particularly through specific genetic changes, are directly linked to the development of Friedreich ataxia.

What the gene does

The frataxin protein, encoded by the FXN gene, is located within the mitochondria, organelles vital for cellular energy production. Although its precise function is still being fully elucidated, frataxin appears to be involved in the assembly of iron-sulphur clusters. These clusters are essential components for the activity of many proteins, including those critical for generating energy within the cell.

A segment within the FXN gene contains a trinucleotide repeat sequence, specifically GAA. In the general population, the number of these GAA repeats is typically fewer than 12, or occasionally between 12 and 33. Expansions of this repeat sequence disrupt the normal production and function of the frataxin protein.

Video: Genetics 101

Chromosome location

The FXN gene is situated on chromosome 9 at position 9q21.11. This gene is a blueprint for the frataxin protein, which consists of 210 amino acid residues.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Genetic variations within the FXN gene can affect the production and function of the frataxin protein. The most common type of pathogenic variant associated with disease involves an expansion of a GAA trinucleotide repeat sequence within the gene. The number of these repeats directly influences the severity and onset of associated conditions.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for FXN.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.317T>C
single nucleotide variant
p.Leu106Ser Pathogenic ★★☆☆ FXN-related disorders
c.169del
Deletion
p.Ser57fs Pathogenic ★☆☆☆ not provided
c.211del
Deletion
p.Gln71fs Pathogenic ★☆☆☆ Friedreich ataxia 1
c.285T>A
single nucleotide variant
p.Tyr95Ter Pathogenic ★☆☆☆ not provided
c.354C>G
single nucleotide variant
p.Tyr118Ter Pathogenic ★☆☆☆ Friedreich ataxia 1
c.460A>T
single nucleotide variant
p.Ile154Phe Pathogenic ★☆☆☆ Friedreich ataxia 1
c.317T>G
single nucleotide variant
p.Leu106Ter Pathogenic - Friedreich ataxia
c.371_376delinsTACACCTTGAGGACA
Indel
p.Asp124_Ser126delinsValHisLeuGluAspThr Pathogenic - Friedreich ataxia 1
c.385-2A>G
single nucleotide variant
- Pathogenic - Friedreich ataxia
c.438C>G
single nucleotide variant
p.Asn146Lys Pathogenic - Friedreich ataxia 1

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the FXN gene are primarily associated with Friedreich ataxia, an inherited neurodegenerative disorder. This condition arises due to an abnormal increase in the number of GAA trinucleotide repeats within the FXN gene, which impairs frataxin production and mitochondrial function. The length of this repeat expansion can correlate with the age at which symptoms typically begin.

UK clinical status

The FXN gene is reviewed on several UK NHS National Genomic Test Directory panels, indicating its significance in diagnostic testing. It has a 'green' status on panels for "Ataxia and cerebellar anomalies - childhood onset", "DDG2P", "Dystonia, chorea or related movement disorder, childhood onset (R57)", "Hereditary ataxia", "Hereditary ataxia, adult onset", "Hereditary neuropathy", "Hereditary neuropathy or pain disorder (R78)", "Hereditary spastic paraplegia, adult onset", "Hereditary spastic paraplegia, childhood onset (R61)", "Likely inborn error of metabolism (R98)", and "Undiagnosed metabolic disorders".

Frequently asked questions

What is the main function of the FXN gene?

The FXN gene provides instructions for making the frataxin protein, which is found in mitochondria and helps in the assembly of iron-sulphur clusters, critical for energy production.

What health condition is associated with FXN gene variants?

Variants in the FXN gene, particularly an expansion of a GAA trinucleotide repeat, are the primary cause of Friedreich ataxia, a progressive neurodegenerative disorder.

How does the GAA repeat expansion in FXN affect protein function?

An abnormally increased number of GAA repeats in the FXN gene leads to reduced production of functional frataxin protein, which then impairs mitochondrial function and energy metabolism within cells.

References

  1. Pandolfo M, Pastore A. The pathogenesis of Friedreich ataxia and the structure and function of frataxin. Journal of neurology. 2009. PMID: 19283345
  2. Hebert MD. Targeting the gene in Friedreich ataxia. Biochimie. 2008. PMID: 18206656
  3. Castaldo I, Pinelli M, Monticelli A. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients. Journal of medical genetics. 2008. PMID: 18697824
  4. Pandolfo M. Friedreich ataxia. Archives of neurology. 2008. PMID: 18852343
  5. Correia AR, Adinolfi S, Pastore A. Conformational stability of human frataxin and effect of Friedreich's ataxia-related mutations on protein folding. The Biochemical journal. 2006. PMID: 16787388
  6. Seznec H, Simon D, Bouton C. Friedreich ataxia: the oxidative stress paradox. Human molecular genetics. 2005. PMID: 15615771
  7. Stehling O, Elsässer HP, Brückel B. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Human molecular genetics. 2004. PMID: 15509595
  8. Adinolfi S, Trifuoggi M, Politou AS. A structural approach to understanding the iron-binding properties of phylogenetically different frataxins. Human molecular genetics. 2002. PMID: 12140189
  9. Adam MP, Bick S, Mirzaa GM. Friedreich Ataxia. 1993. PMID: 20301458
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .